Results 151 to 160 of about 7,256,250 (309)
LivAge: An Online Aging Clock for Murine Transcriptomic Age Estimation. [PDF]
Celemín-Capaldi V +6 more
europepmc +1 more source
Cancer treatment is associated with measurable acceleration of biological aging across epigenetic, telomere, senescence, and immune biomarkers. However, biomarker validation and interventional strategies remain limited, especially in hematologic malignancies, underscoring the need for standardized multi‐omic aging assessments and adequately powered ...
Moataz Ellithi +3 more
wiley +1 more source
Digital OPG forensic tool for biological sex determination and age estimation in Malaysians - a retrospective study. [PDF]
Jaiseelal SR +5 more
europepmc +1 more source
ABSTRACT Advancing artificial intelligence (AI) has transformed learning and work, yet higher education and professional development programs have not systematically equipped learners for AI‐prevalent environments. This lack of preparation creates uncertainty regarding control, responsibility, trust, and accountability.
Moon‐Heum Cho, Jerusalem Merkebu
wiley +1 more source
Comparing Deep Plane and Superficial Musculoaponeurotic System Facelifts Using Artificial Intelligence-Based Age Estimation. [PDF]
Tan SJ, Steppe K, Mims MM.
europepmc +1 more source
Posterior Cortical Atrophy in the Asia‐Pacific: A Report From the PCA Asian Workgroup
ABSTRACT Objective Posterior Cortical Atrophy (PCA) is a distinct dementia syndrome primarily affecting spatial abilities and visual processing. It is associated with degeneration in the posterior part of the brain. PCA is subclassified into PCA‐pure and PCA‐plus syndromes based on consensus criteria.
Yuttachai Likitjaroen +11 more
wiley +1 more source
Shoulder MRI for Forensic Age Estimation: Ossification Staging of the Proximal Humeral Epiphysis. [PDF]
Saka NE +6 more
europepmc +1 more source
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold +12 more
wiley +1 more source
Population-adapted Nolla method for dental age estimation in Northwestern Romanian children. [PDF]
Moga LI +6 more
europepmc +1 more source

